Cargando…

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report

The reactivation of hepatitis B virus (HBVr) in patients undergoing pharmacological immunosuppression is a potentially fatal clinical event that may occur in patients with overt or occult HBV infection. The risk of HBVr is mainly determined by the type of immunosuppressive therapy and the HBV serolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caviglia, Gian Paolo, Zorzi, Antonella, Rizzetto, Mario, Mirandola, Massimo, Olivero, Antonella, Carolo, Giada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700299/ https://www.ncbi.nlm.nih.gov/pubmed/34943420 http://dx.doi.org/10.3390/diagnostics11122185

Ejemplares similares

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
por: Caviglia, Gian Paolo, et al.
Publicado: (2012)

Hepatitis B virus S gene escape mutants
por: Purdy, Michael A.
Publicado: (2007)

Prevention of Hepatitis B reactivation in the setting of immunosuppression
por: Pattullo, Venessa
Publicado: (2016)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures
por: Ghamari, Shiva, et al.
Publicado: (2013)

Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy
por: Fusco, Dahlene N., et al.
Publicado: (2018)

Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification
por: Olivero, Antonella, et al.
Publicado: (2022)

The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report
por: Foroghi Biland, Luca, et al.
Publicado: (2019)

Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021)

Pathogenicity of neutralization escape mutants of mouse hepatitis virus : correlation with T- and B-cell depletions
por: Lamontagne, L., et al.
Publicado: (1994)

Treatment of Hepatitis B Virus Cirrhosis
por: Rizzetto, Mario
Publicado: (2012)

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
por: Inoue, Jun, et al.
Publicado: (2019)

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Hepatitis B virus genotypes and precore and core mutants in UAE patients
por: Alfaresi, Mubarak, et al.
Publicado: (2010)

Immunosuppression in Patients with Chronic Hepatitis B
por: Seetharam, Anil, et al.
Publicado: (2014)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

1026. Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody after Switching to Antiretroviral Therapy without Hepatitis B Activity
por: Denyer, Rachel V, et al.
Publicado: (2023)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018)

Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies
por: Pei, Rongjuan, et al.
Publicado: (2014)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2021)

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
por: Washizaki, Ayaka, et al.
Publicado: (2022)

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
por: Watanabe, Takehisa, et al.
Publicado: (2021)

Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients
por: Yan, Linlin, et al.
Publicado: (2015)

Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity
por: Hossain, Md. Golzar, et al.
Publicado: (2017)

Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
por: Lau, George, et al.
Publicado: (2022)

Innate and adaptive immune escape mechanisms of hepatitis B virus
por: Zhao, Hua-Jun, et al.
Publicado: (2022)

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants
por: Lefeuvre, Caroline, et al.
Publicado: (2022)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023)

Hepatitis B and Hepatitis C Reactivation in the Biologic Era
por: Bojito-Marrero, Lizza, et al.
Publicado: (2014)

Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child.
por: Lee, K. M., et al.
Publicado: (2001)

Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants
por: Zhang, Mingshun, et al.
Publicado: (2013)

Patterns of hepatitis B virus S gene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan
por: Ababneh, Nidaa A., et al.
Publicado: (2019)

1066. Immune Escape Mutant Detection Using Commercially Available Methods for Hepatitis B Surface Antigen Serological Testing
por: Gish, Robert, et al.
Publicado: (2020)

Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant
por: Hossain, Md. Golzar, et al.
Publicado: (2021)

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
por: Tavakolpour, Soheil, et al.
Publicado: (2016)

Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review)
por: Baroiu, Liliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ackbllr8sek0dbap8ugi5eej01